Fundraising Fox

Islet Sciences

Yorba Linda, US · Nevada corporation

Biotech

Founders & leadership

DE
David E. WilderExecutive
LK
Larry K. EllingsonChairman, Chief Executive Officer and President
RE
RICHARD EGANCFO

Board

EM
Eugene M. MannheimerBoard director
RD
Richard D. PilnikBoard director
JF
John F. SteelBoard director
JA
James A. HarperBoard director
GR
Gary R. KeelingBoard director
JP
JOEL PERLINBoard director
GT
GEORGE TODAROBoard director

Reported raises · per SEC filings

Form D private placements

$2.3M disclosed across 4 rounds · 2011–2015

▶$30KraisedDec 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eugene M. MannheimerDirector
  • Richard D. PilnikDirector
  • John F. SteelDirector
  • David E. WilderExecutive Officer
  • Larry K. EllingsonExecutive Officer, Director
  • James A. HarperDirector
  • Gary R. KeelingDirector
Offering amount
$1.5M
Amount sold
$30K
Sales commissions
$165K
Proceeds to insiders
$112.5K
Placement agents
Cova Capital Partners, LLC
First sale
Dec 2015
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedApr 2014 · 35 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • RICHARD EGANExecutive Officer
  • WILLIAM WILKISONExecutive Officer, Director
  • MICHAEL LUTHERDirector
  • ERIC BARNETTDirector
  • JOEL PERLINDirector
  • JAMES GREENExecutive Officer, Director
  • JOHN STEELDirector
Offering amount
$2.5M
Amount sold
$2.2M
Minimum investment
$100K
Sales commissions
$266.7K
Placement agents
COVA CAPITAL PARTNERS, LLC
First sale
Dec 2013
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1raisedMar 2012 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JERRY NADLERDirector
  • JOEL PERLINDirector
  • JOHN STEELExecutive Officer, Director
  • GEORGE TODARODirector
  • RICHARD EGANExecutive Officer
Offering amount
$1
Amount sold
$1
First sale
Mar 2012
Incorporated
Corporation, Nevada
Federal exemptions
06
Full filing on SEC EDGAR ↗
▶$1raisedJan 2012 · 71 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JOEL PERLINDirector
  • GEORGE TODARODirector
  • JOHN STEELExecutive Officer, Director
  • RICHARD EGANExecutive Officer
Offering amount
$1
Amount sold
$1
First sale
Dec 2011
Incorporated
Corporation, Nevada
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Islet Sciences Enters Into Exclusive License Agreement for Phase 2 SGLT2 Inhibitor Remogliflozin Etabonateglobenewswire.com · Mar 2015Islet Sciences Engages Investment Bank As Financial Advisor - BioSpacebiospace.com · Feb 2015Islet Sciences Chief Scientific Officer Receives $1.27 million in Grant from JDRF to Create Innovative Diabetes Treatmentsprnewswire.com · Jun 2013Islet Sciences, Inc. Technologies Featured in Five Separate Presentations at the American Diabetes Association Annual Meetingprnewswire.com · Jun 2013

Frequently asked questions

How much funding has Islet Sciences raised?
Islet Sciences has disclosed $2.3M raised across 4 rounds.
Where is Islet Sciences headquartered?
Islet Sciences is headquartered in Yorba Linda, US.